<DOC>
	<DOCNO>NCT00283439</DOCNO>
	<brief_summary>The purpose study identify well-tolerated , effective dose schedule AMG 531 treatment Chemotherapy Induced Thrombocytopenia ( CIT ) subject lymphoma receive multi-cycle chemotherapy .</brief_summary>
	<brief_title>A Dose Schedule Finding Trial With AMG 531 Chemotherapy Induced Thrombocytopenia ( CIT ) Adults With Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>Histologically confirm Hodgkin 's lymphoma NonHodgkin 's lymphoma receiving Q14 , Q21 , Q28 day CHOP , ICE , ESHAP , DHAP chemotherapy ; without Rituximab Has adequate bone marrow function ; platelet count &gt; 100 x 10^9/L day initiation study chemotherapy next treatment cycle absolute neutrophil count , ANC &gt; = 1 x 10^9/L , hemoglobin &gt; = 9.5 g/dL Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Has adequate liver function must able receive chemotherapy regimen first treatment cycle receive prior qualify cycle must experience Common Terminology Criteria ( CTC ) grade 3 4 thrombocytopenia ( platelet count &lt; 50 x 10^9/L ) result chemotherapy administer cycle immediately precede study entry serum creatinine concentration &lt; = 2 mg/dl More 1 prior relapse chemotherapy regimen Sepsis , disseminate coagulation condition may exacerbate thrombocytopenia Significant bleeding ( CTC grade 3 4 ) History thromboembolic disease Subjects identify clinical history and/or serological test either acute chronic hepatitis B C infection HIV positive Use nitrosourea mitomycinC Has receive thrombocytopenic growth factor Has receive marrow peripheral blood stem cell infusion Known hypersensitivity recombinant E. coliderived product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>NHL</keyword>
	<keyword>chemotherapy induce thrombocytopenia</keyword>
	<keyword>CIT</keyword>
	<keyword>ICE</keyword>
	<keyword>RICE</keyword>
	<keyword>Hodgkin 's Lymphoma</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>CHOP</keyword>
	<keyword>ESHAP</keyword>
	<keyword>DHAP</keyword>
	<keyword>R-CHOP</keyword>
	<keyword>R-ESHAP</keyword>
	<keyword>R-DHAP</keyword>
</DOC>